Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;35(5):800-805.
doi: 10.1002/ncp.10554. Epub 2020 Jul 15.

Gastrointestinal Manifestations of COVID-19: Impact on Nutrition Practices

Enrik John T Aguila  1 , Ian Homer Y Cua  1 , Joy Arabelle C Fontanilla  2 , Vince Leenard M Yabut  3 , Marion Frances P Causing  4
Affiliations
Review

Gastrointestinal Manifestations of COVID-19: Impact on Nutrition Practices

Enrik John T Aguila et al. Nutr Clin Pract. 2020 Oct.

Abstract

Although Coronavirus disease 2019 (COVID-19) is primarily a respiratory disease, growing evidence shows that it can affect the digestive system and present with gastrointestinal (GI) symptoms. Various nutrition societies have recently published their guidelines in context of the pandemic, and several points emphasize the impact of these GI manifestations on nutrition therapy. In patients with COVID-19, the normal intestinal mucosa can be disrupted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, and this could result in GI symptoms and a compromise in nutrient absorption. Optimization of oral diet is still recommended. However, given the GI effects of COVID-19, a fraction of infected patients have poor appetite and would not be able to meet their nutrition goals with oral diet alone. For this at-risk group, which includes those who are critically ill, enteral nutrition is the preferred route to promote gut integrity and immune function. In carrying this out, nutrition support practices have been revised in such ways to mitigate viral transmission and adapt to the pandemic. All measures in the GI and nutrition care of patients are clustered to limit exposure of healthcare workers. Among patients admitted to intensive care units, a significant barrier is GI intolerance, and it appears to be exacerbated by significant GI involvement specific to the SARS-CoV-2 infection. Nevertheless, several countermeasures can be used to ease side effects. At the end of the spectrum in which intolerance persists, the threshold for switching to parenteral nutrition may need to be lowered.

Keywords: COVID-19; SARS-CoV-2; digestive system; enteral nutrition; gastrointestinal symptoms; gastrointestinal tract; nutrition support; parenteral nutrition.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ungaro RC, Sullivan T, Colombel JF, Patel G. What gastroenterologists and patients should know about COVID‐19? Clin Gastroenterol Hepatol. 2020;18(7):1409‐1411. - PMC - PubMed
    1. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS‐CoV‐2. Gastroenterology. 2020;158(6):1831‐1833.e3. - PMC - PubMed
    1. Aguila EJ, Cua IH, Dumagpi JE, Francisco CP, Raymundo NT, Sy‐Janairo ML, Cabral‐Prodigalidad PA, Lontok MA. COVID‐19 and its effects on the digestive system and endoscopy practice JGH Open. 2020;4(3):324–331. - PMC - PubMed
    1. Pan L, Mu M, Ren HG, et al. Clinical characteristics of COVID‐19 patients with digestive symptoms in Hubei, China: a descriptive, cross‐sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766‐773 - PMC - PubMed
    1. Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus‐infected pneumonia. J Med Virol. 2020;92(6):680‐682. - PMC - PubMed